Literature DB >> 23916657

Repeated valproate treatment facilitates fear extinction under specific stimulus conditions.

Stephen C Heinrichs1, Kimberly A Leite-Morris, Ann M Rasmusson, Gary B Kaplan.   

Abstract

Single dose treatment with histone deacetylase inhibitor (HDACi) agents has been shown to enhance extinction learning in rodent models under certain conditions. The present novel studies were designed to examine the effects of repeated HDACi treatment, with valproate or sodium butyrate, on the extinction of conditioned fear. In Experiments 1 and 2, short duration CS exposure (30s) in combination with vehicle administration progressively attenuated conditioned fear responses over 40 or more sessions. This effective extinction training was not augmented by HDACi treatments. In Experiment 3, we used a long duration CS exposure (120 s) to weaken extinction training. With these extinction parameters, repeated valproate treatment substantially facilitated the acquisition and retention of fear extinction. Results of this study extend previous work suggesting that HDACi's have utility in augmenting the efficiency of fear extinction, although their apparent benefits are critically dependent upon specific parameters of extinction training.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Conditioned fear; Extinction learning; HDAC; HDACi; Histone deacetylase inhibitors; Mouse; PTSD; SB; Sodium butyrate; VPA; Valproate; histone deacetylase; histone deacetylase inhibitor; post-traumatic stress disorder; sodium butyrate; valproic acid

Mesh:

Substances:

Year:  2013        PMID: 23916657     DOI: 10.1016/j.neulet.2013.07.035

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Histone deacetylase and acetyltransferase inhibitors modulate behavioral responses to social stress.

Authors:  Katharine E McCann; Anna M Rosenhauer; Genna M F Jones; Alisa Norvelle; Dennis C Choi; Kim L Huhman
Journal:  Psychoneuroendocrinology       Date:  2016-10-26       Impact factor: 4.905

Review 2.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 3.  Reconsolidation and extinction: Using epigenetic signatures to challenge conventional wisdom.

Authors:  Thekla J Hemstedt; K Matthew Lattal; Marcelo A Wood
Journal:  Neurobiol Learn Mem       Date:  2017-01-21       Impact factor: 2.877

Review 4.  Neurotransmitter, Peptide, and Steroid Hormone Abnormalities in PTSD: Biological Endophenotypes Relevant to Treatment.

Authors:  Ann M Rasmusson; Suzanne L Pineles
Journal:  Curr Psychiatry Rep       Date:  2018-07-17       Impact factor: 5.285

Review 5.  Can fear extinction be enhanced? A review of pharmacological and behavioral findings.

Authors:  Paul J Fitzgerald; Jocelyn R Seemann; Stephen Maren
Journal:  Brain Res Bull       Date:  2013-12-25       Impact factor: 4.077

6.  Valproate Adjuvant Cognitive Behavioral Therapy in Panic Disorder Patients With Comorbid Bipolar Disorder: Case Series and Review of the Literature.

Authors:  Kwang-Yeon Choi
Journal:  Psychiatry Investig       Date:  2022-08-24       Impact factor: 3.202

7.  The effects of valproic acid on appetitive and aversive instrumental learning in adult rats.

Authors:  John J Orczyk; Melissa K Banks; Preston E Garraghty
Journal:  Front Behav Neurosci       Date:  2014-04-01       Impact factor: 3.558

Review 8.  Histone-acetylation: a link between Alzheimer's disease and post-traumatic stress disorder?

Authors:  Sanaz Bahari-Javan; Farahnaz Sananbenesi; Andre Fischer
Journal:  Front Neurosci       Date:  2014-06-24       Impact factor: 4.677

9.  Sex-Dependent Effects of the Histone Deacetylase Inhibitor, Sodium Valproate, on Reversal Learning After Developmental Arsenic Exposure.

Authors:  Christina R Steadman Tyler; Jane J W Smoake; Elizabeth R Solomon; Estrella Villicana; Kevin K Caldwell; Andrea M Allan
Journal:  Front Genet       Date:  2018-06-15       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.